Compass Therapeutics, Inc. short interest in 2022
In 2022, Compass Therapeutics, Inc.'s disclosed short interest ran from 0.32% of shares outstanding on 28 Feb 2022 to 0.25% on 15 Dec 2022, a change of -0.07 percentage points. The year's high was 0.74% on 15 Mar 2022 and its low 0.02% on 31 Aug 2022, averaging 0.24% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.47 days on 15 Mar 2022. Full history: Compass Therapeutics, Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 0.32% (28 Feb 2022)
- End of year
- 0.25% (15 Dec 2022)
- Change
- -0.07 pp
- High
- 0.74% (15 Mar 2022)
- Low
- 0.02% (31 Aug 2022)
- Average
- 0.24%
- Highest days to cover
- 6.47 (15 Mar 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Feb 2022 | 0.32% | 2.06 | |
| 15 Mar 2022 | 0.74% | 6.47 | |
| 31 Mar 2022 | 0.74% | 2.82 | 10-K filed |
| 29 Jul 2022 | 0.05% | 1.00 | 10-Q filed |
| 15 Aug 2022 | 0.04% | 1.00 | 10-Q filed |
| 31 Aug 2022 | 0.02% | 1.00 | |
| 15 Sep 2022 | 0.05% | 1.00 | |
| 15 Nov 2022 | 0.09% | 1.00 | 10-Q filed |
| 30 Nov 2022 | 0.12% | 1.53 | |
| 15 Dec 2022 | 0.25% | 1.94 |
See also: Compass Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.